US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 730.300
  • +14.040+1.96%
Close Jan 7 16:00 ET
  • 733.000
  • +2.700+0.37%
Post 16:32 ET
80.25BMarket Cap18.06P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.564B--
--2024/Q4-- / 3.762B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.564B--
--2024/Q4-- / 3.762B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

  • Regeneron Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 07:21 ET

  • Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2024 Financial and Operating Results

    Oct 31, 2024 07:15 ET

  • Regeneron Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1, 2024 07:21 ET

  • Regeneron Pharmaceuticals | 8-K: Regeneron Reports Second Quarter 2024 Financial and Operating Results

    Aug 1, 2024 07:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 7, 2025

    Buy

    • Buy

      77.27%

    • Hold

      18.18%

    • Sell

      4.55%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday+1.31%